December 24, 2025 11:49 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Delhi erupts over lynching of Hindu man in Bangladesh; protest outside High Commission | Targeted killing sparks global outrage: American lawmakers condemn mob lynching of Hindu man in Bangladesh | Assam on a ‘powder keg’: Himanta Biswa Sarma flags demographic shift, Chicken’s Neck fears | Bangladesh on edge: Student leader shot as pre-poll violence deepens after Hadi killing | Historic deal sealed: India, New Zealand sign landmark Free Trade Agreement in record time | Supreme court snubs urgent plea to stop PMO’s chadar offering at Ajmer Sharif | Emergency landing drama: Air India flight heads back to Delhi after engine malfunction! | PM Modi slams ‘cut and commission’ TMC in virtual Taherpur address | US launches Operation Hawkeye Strike in Syria targeting ISIS after Americans killed | Horror on tracks: Rajdhani Express ploughs into elephant herd, eight killed in Assam
India COVID19
Unsplash

COVID-19: India to supply vaccines to six nations, including Nepal and Bangladesh 

| @indiablooms | Jan 20, 2021, at 02:44 pm

New Delhi: The Government of India has said it received several requests for the supply of Indian manufactured vaccines against COVID-19 from neighbouring and key partner countries. 

In response to these requests, and in keeping with India’s stated commitment to use India’s vaccine production and delivery capacity to help all of humanity fight the Covid pandemic, supplies under grant assistance to Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles will begin from 20 January 2021, the Ministry of External Affairs said in a statement. 

"In respect of Sri Lanka, Afghanistan and Mauritius, we are awaiting their confirmation of necessary regulatory clearances," read the statement.

Immunization programme is being implemented in India, as in other countries, in a phased manner to cover the healthcare providers, frontline workers and the most vulnerable. 
Keeping in view the domestic requirements of the phased rollout, India will continue to supply COVID-19 vaccines to partner countries over the coming weeks and months in a phased manner. 

It will be ensured that domestic manufacturers will have adequate stocks to meet domestic requirements while supplying abroad.

Prior to the delivery of vaccines, a training programme, covering administrative and operational aspects, is being conducted on 19-20 January 2021 for immunization managers, cold chain officers, communication officers and data managers of the recipient countries, both at national and provincial levels.

India had earlier supplied hydroxychloroquine, Remdesivir and paracetamol tablets, as well as diagnostic kits, ventilators, masks, gloves and other medical supplies to a large number of countries during the COVID19 pandemic.

India has also provided training to several neighbouring countries to enhance and strengthen their clinical capabilities, under the Partnerships for Accelerating Clinical Trials (PACT) programme. 

Separately, several training courses have been organized for healthcare workers and administrators of partner countries under the Indian Technical and Economic Cooperation (ITEC) programme, sharing our experience in dealing with the pandemic.

In an ongoing effort, India will continue to supply countries all over the world with vaccines. This will be calibrated against domestic requirements and international demand and obligations, including under GAVI’s Covax facility to developing countries.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.